Illumina provides sequencing and array solutions to advance genomic research. Their products include instruments, kits, reagents, software, and analysis services.

Illumina

BaseSpace Informatics Suite

Illumina For Startups

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

Oxford Nanopore Technologies

SomaLogic

Twist Bioscience

GenoLogics

Ginkgo Bioworks

Grail

Helixis

Bank of America

Lombard Odier

Chase Capital Partners

Chevron Technology Ventures

ARCH Venture Partners

State Farm

Tredegar Investments

Venrock

CW Group

The "chewing gum," made from birch bark pitch and saliva, likely served as glue for tools. Researchers analyzed the #DNA in the gum, revealing the Stone Age teenagers' diet, including deer, trout, apple, duck, fox, and hazelnuts.

May the Year of the Dragon bring you joy, prosperity, and good luck! 🐲 

In 2023, we launched a novel technology to help reach the darkest corners of the genome and make long-read sequencing accessible. Now, we have built upon Illumina Complete Long Read technology with a new highly accurate, targeted long-read solution—compatible with predesigned and fully custom panels—offering greater flexibility for long-read sequencing.
 
Why? To help scientists access more of the genome and find answers to improve human health.

Learn more about Illumina Complete Long Read Prep with Enrichment:
https://bit.ly/3Oliav7


Good things come in threes, and the lineup of #NovaSeqX flow cells are no different. The addition of the 1.5B flow cell to the reagent kit portfolio provides unmatched flexibility to take on smaller batch or pilot projects. 

Scale up your way with the NovaSeq X Series: https://bit.ly/3u8LlKS

PacBio is a biotechnology company that develops and manufactures DNA sequencing systems.

PacBio

Oxford Nanopore is a biotechnology company specializing in nanopore-based electronic molecular analysis systems.

Oxford Nanopore

Thermo Fisher Scientific is a multinational biotechnology product development company.

Thermo Fisher Scientific

Affymetrix is a biotechnology company that provides products for genetic analysis.

Affymetrix

Biostars is a platform for bioinformatics and computational biology.

Biostars

Complete Genomics is a biotechnology company specializing in human genome sequencing and analysis.

Complete Genomics

Caliper Life Sciences is a company that develops and markets microfluidic lab-on-a-chip technologies.

Caliper Life Sciences

Sequentify is a biotechnology company that offers sequencing and bioinformatics solutions.

Sequentify

Algorithmic Biologics is a company specializing in computational biology and bioinformatics.

Algorithmic Biologics

P4 Medical Laboratory is a medical diagnostics laboratory offering genetic testing services.

P4 Medical Laboratory

Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company's portfolio encompasses sequencing kits and reagents, sequencing tools and systems, microarray kits and reagents, molecular biology reagents, and arrays and reagents. Illumina serves pharmaceutical companies, academic institutions, genomic research centers, biotechnology companies, and clinical research organizations.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Feb 15, 2024 6:15 PM	baa0d2c0
public peers	general	Oct 2, 2024 2:39 PM	a529aee8
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 2, 2024 2:39 PM	e27e11ca
crunchbase trigger	general
crunchbase profile	general
li profile	general	Feb 15, 2024 6:15 PM	b712155a
translate crunchbase fundingrounds	general
peers	general	Oct 2, 2024 2:39 PM	180b7e50
news basic	general	Oct 2, 2024 2:39 PM	1171167c
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:ILLUMINA

Illumina